Literature DB >> 18056252

Treatment of Tourette's syndrome with finasteride.

Marco Bortolato, Antonella Muroni, Francesco Marrosu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056252     DOI: 10.1176/appi.ajp.2007.07060978

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  18 in total

1.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

2.  Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Authors:  Laura J Mosher; Roberto Cadeddu; Sabrina Yen; Jeffrey L Staudinger; Francesco Traccis; Stephen C Fowler; Jamie L Maguire; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2019-06-14       Impact factor: 4.905

Review 3.  Emerging treatments for Tourette's disorder.

Authors:  Michael H Bloch
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

4.  Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

Authors:  Roberto Frau; Federico Abbiati; Valentina Bini; Alberto Casti; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

Review 5.  What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Neurosci Biobehav Rev       Date:  2016-12-08       Impact factor: 8.989

6.  Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Authors:  Roberto Frau; Giuliano Pillolla; Valentina Bini; Simone Tambaro; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2012-08-09       Impact factor: 4.905

Review 7.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

8.  Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.

Authors:  Li Li; Yun-Xiao Kang; Xiao-Ming Ji; Ying-Kun Li; Shuang-Cheng Li; Xiang-Jian Zhang; Hui-Xian Cui; Ge-Ming Shi
Journal:  CNS Neurosci Ther       Date:  2017-12-06       Impact factor: 5.243

Review 9.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

10.  Steroid 5α-reductase in adult rat brain after neonatal dihydrotestosterone administration.

Authors:  P Sánchez; J M Torres; B Castro; R G Del Moral; J de Dios Luna; E Ortega
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.